-
Judge “Not Sympathetic” to Ford’s Attempt to Evade $9.1 Million Mesothelioma Verdict
Indicating that he was “not sympathetic” to arguments made by Ford Motor Company against having to pay a $9.1 million mesothelioma judgment, Delaware Superior Court Judge Ferris W. Wharton rejected arguments that the auto giant was not treated well in court and deserved a new trial. The case involved the death of Larry Knecht, a
-
World Cancer Day Highlights Awareness: Know the Warning Signs of Mesothelioma
Today is February 4th, the day that the mesothelioma community and cancer community around the world marks as World Cancer Day each year. Though much of what is highlighted during this annual celebration is the innovation and accomplishments that researchers have made towards finding a cure, there is an equally robust focus on making sure
-
Consolidating Mesothelioma Lawsuits Can Offer Benefits to Victims
Once a victim of asbestos exposure is diagnosed with mesothelioma, they have numerous decisions to make, and one of the most important for their family is whether or not to pursue legal action against the company that exposed them to the carcinogenic material. Filing a mesothelioma lawsuit can lead to significant compensation that both pays
-
Promising New Mesothelioma Clinical Trial Started This Week
Biotech company Curis, Inc., a leader in innovative cancer treatments, has announced that as part of a Phase I clinical trial of their new drug CA-170, they’ve enrolled and dosed their first mesothelioma patient. The oral medication targets cancer cells that express high levels of VISTA, a protein understood to help cancer cells resist treatment.
-
Study Highlights Mesothelioma Risk Among U.S. Navy Veterans
It has long been known that mesothelioma has a significantly higher incidence among America’s veterans when compared to the rest of the population, and that those who served in the Navy have the highest representation among that group. Now a newly published report prepared by researchers at Vanderbilt University has clearly defined the extent of
-
Israeli Scientists Believe They’ve Found A Cure for All Cancers, Including Mesothelioma
Mesothelioma research has focused on the specific challenges presented by the rare and fatal cancer caused by exposure to asbestos. But a team of Israeli scientists from a company called Accelerated Evolution Biotechnologies Ltd (AEBi) believes that it has found an innovative solution that will work for every type of cancer. They are beginning clinical
-
FDA Approves Genetics-Based Cancer Treatment That May Be Used in Mesothelioma Patients
A first-of-its-kind cancer drug has just been approved by the U.S. Food and Drug Administration for use in patients with many types of cancer, including malignant mesothelioma. The drug is manufactured by Bayer and is called larotrectinib, though it is sold under the brand name Vitrakvi. It is a genetics-based treatment that is provided based
-
Supplier Attempts to Evade Mesothelioma Claim Based on Address Confusion
When a mesothelioma lawsuit is filed against a company, accusing them of being responsible for a person’s terminal illness, there are generally two different paths that they can take. In some cases organizations want the claim to go away as quickly and quietly as possible: they make a settlement offer and negotiate with the victim
-
Gold Nanoparticle Delivery of Mesothelioma Drugs Shows Significant Advantage
A new study conducted by Italian researchers may represent a breakthrough in achieving more effective delivery of mesothelioma treatment drugs. In a study published this week in the International Journal of Nanomedicine, scientists explored identifying a target on the surface of malignant pleural mesothelioma cells and then programming gold nanoparticles loaded with the chemotherapy drug pemetrexed
-
NY Appeals Court to Determine Whether Mesothelioma Case Can Move Forward
When Mason South joined a group of other Merchant Marines suing Texaco back in the 1990s, he had no idea that he would be diagnosed with malignant mesothelioma nearly 25 years later. The plaintiffs had sued the company in federal court over damages they suffered from exposure to asbestos and second-hand smoke on merchant ships,
-
Phase 2 Clinical Trial of Nivolumab Use for Mesothelioma Shows Promise
Like many other breakthrough cancer medications, nivolumab is a drug that was first developed for more common types of cancer and is only now being tested for use in malignant mesothelioma. The drug is a monoclonal antibody that works as a checkpoint inhibitor: this means that it works to block a signal that cancer cells
-
Treatment for Mesothelioma and Other Cancers May Benefit from Use of Special Sugar
Malignant mesothelioma and other forms of cancer require glucose, the simple sugar we source from carbohydrates, to fuel their growth. Now researchers from the Cancer Research UK Beatson Institute have found that by dosing cancer with a different type of sugar it can interrupt glucose’s ability to feed the tumors, slowing cancer’s growth without impacting
-
Mesothelioma Victim’s Claim Against Ford Motor Co. To Move Forward
A mesothelioma diagnosis is devastating in many ways. One of the most disappointing moments for victims comes when they learn that their illness was preventable: companies that used asbestos in their products were aware of its dangers and yet continued to use the mineral in order to continue reaping big profits. Ford Motor Company is
-
Study Seeks to Determine Most Advantageous Mesothelioma Treatment Order
Healthcare professionals treating patients diagnosed with malignant mesothelioma have identified surgery and chemotherapy as the two most effective treatment modalities currently available, but there are many variables in how these protocols are applied. There are multiple types of surgery used to resect mesothelioma’s tumors, multiple types of chemotherapy medication provided to patients, and even variations
-
Following Judge’s Mesothelioma Death, Court Scolds County Over Asbestos Exposure
James Farris died of malignant peritoneal mesothelioma suddenly and without warning. He had been feeling ill for some time but had not pursued a diagnosis. Then, in 2004 he gave a speech to a gathered group, went home and told his wife he couldn’t continue with his work, went to the hospital and died nine
-
Treatment Results for Chinese Woman with Mesothelioma Raise Hopes for New Drug
Chinese physicians confronted with an acute case of mesothelioma may have stumbled upon a third line of treatment to extend overall patient survival. Physicians at 363 Hospital in Cheng Du were asked to treat a 58-year-old woman who arrived at the hospital with uncomfortable respiratory symptoms, including breathlessness, fluid in her lungs and a tightness
-
60-Year-Old Mother of Two Dies of Mesothelioma After 45 Years of Baby Powder Use
When Michelle Germaine was diagnosed with epithelial mesothelioma in February of 2017, it was too late for her to stop using Johnson & Johnson’s Baby Powder. The 60-year-old woman had been using talc-based powders since she was a girl in Haiti, and had continued that practice once she immigrated to the United States in 1971,
-
For UK Mesothelioma and Asbestos Victims, Filing A Lawsuit Takes A Village
Anybody who has pursued a mesothelioma or asbestos-related disease lawsuit in the United States knows how heavily that process relies on expert witnesses and formal depositions taken from suppliers to former employers, former colleagues, and others who might have insider knowledge of the victim’s working environment. In the United Kingdom, the pursuit of legal action
-
Researchers Find Molecule that Can Stop Mesothelioma Cells from Tricking the Immune System
One of the most challenging aspects about cancers like malignant mesothelioma is the way that it continues to grow and spread. Researchers have found that cancer cells actually trick the immune system into ignoring them instead of attacking them, thus allowing it to metastasize and cause increasing damage. But researchers from Rush Medical College in Chicago,
-
Another Baby Powder Mesothelioma Lawsuit Moves Forward in New York City
Over and over in America’s courtrooms, Johnson & Johnson’s Baby Powder is being accused of causing the deadly asbestos-related disease known as malignant mesothelioma, and over and over again the company tries to use legal maneuvers to avoid its legal responsibility. It happened again recently in the Supreme Court of New York County, when the
